Sign In
Buy CAPE
$32.64
-0.0400 (-0.122%)
At Close: Jul 13, 2026
Top 10 Charts of 2026: Mid-Year Review
12:02pm, Monday, 13'th Jul 2026
Navigating the macroeconomic landscape in the first half of 2026 has been a study in contrasts. Markets have marched toward all-time highs even as historic valuation metrics flash warning signs behind
Stocks Surged in Q2 2026, but Is the Market Getting Too Expensive?
06:51pm, Wednesday, 01'st Jul 2026
While the market's momentum has been undeniable, valuation metrics are flashing caution signs that investors shouldn't ignore following one of the strongest periods for U.S. equities in recent memory.
Barclays Launches Shiller Barclays CAPE® US SMID Sector Index
10:00am, Wednesday, 24'th Jun 2026
Barclays today announced the launch of the Shiller Barclays CAPEÂ US SMID Sector Index, expanding its long-standing Shiller Barclays CAPEÂ index family to U.
Why the Bond King is Betting on Hikes, Hype & Global Rotation
07:27am, Tuesday, 23'rd Jun 2026
The fixed income asset class has been anything but sleepy thus far this year. In fact, fixed income investors may be experiencing bouts of insomnia as higher-for-longer interest rates and a new Fed ch
Build On a Strong Earnings Season With These 3 ETFs
07:20am, Friday, 12'th Jun 2026
Despite numerous reasons why investors might expect otherwise, 2026 appears to be off to an excellent start across many parts of the market. As evidenced by strong earnings growth often topping analys
The Stock Market Is at a 40-to-1 CAPE Ratio Seen Only Twice Before. 1929 and 1999 Preceded Crashes.
07:33am, Tuesday, 26'th May 2026
Although the S&P 500 has climbed roughly 9% year to date and about 28% over the past year, Wall Street is now sitting on a valuation signal it has only ever flashed twice before. Tom Bilyeu, speaking
Shiller CAPE U.S. Equities ETF $CAPE Holdings Reduced by Evensky & Katz LLC
04:54am, Monday, 09'th Mar 2026
Evensky and Katz LLC lowered its position in Shiller CAPE U.S. Equities ETF (NYSEARCA:CAPE) by 3.5% during the undefined quarter, according to its most recent disclosure with the Securities and Exchan
Bond King Reviews 2025, Offers Clues to 2026 in Webcast
03:39pm, Wednesday, 14'th Jan 2026
DoubleLine CEO/CIO Jeffrey Gundlach waxed market poetic in a recent Just Markets webcast. He looked back at 2025 and ahead in 2026 for opportunities with a barrage of charts to support his assertions
CAPE: An Alternative Take On The Value Investment Theme With Mixed Results
11:06am, Thursday, 14'th Aug 2025
CAPE: An Alternative Take On The Value Investment Theme With Mixed Results
Gundlach: Illiquid Assets Don't Belong in Liquid Vehicles
04:09pm, Wednesday, 11'th Jun 2025
While many in the financial industry have lauded the expansion of the ETF vehicle as a significant step toward democratization, particularly for making previously inaccessible assets like cryptocurren
CAPE: Good Intentions, Mediocre Results
01:54pm, Friday, 28'th Feb 2025
CAPE is based on the work of Professor Robert Shiller of Yale, adapted by DoubleLine, the ETF's parent company. The fund has a good idea and design, but the execution has not been there. The process h
Semi-Transparent ETFs Are Alive and Well
09:23am, Wednesday, 18'th Oct 2023
Active ETFs have gained in popularity in recent years. However, some pundits have prematurely taken out their shovels for some funds.
DoubleLine's ETF Lineup Doubled in Size
11:17am, Wednesday, 31'st May 2023
Just over a year ago, DoubleLine entered the ETF market and in May 2023 doubled its lineup. The new products tap into the prominent active management firm's expertise.
Gundlach's DoubleLine Launches 2 Real Estate ETFs
05:34pm, Thursday, 06'th Apr 2023
The launches come during a troubling time for the real estate industry.
Korea Ginseng Corp. Sponsors Premier Awards Event Honoring Asian and Pacific Islander American Women in Hollywood
08:34pm, Tuesday, 28'th Mar 2023
Partners with Coalition for Asian Pacifics in Entertainment(CAPE) to Showcase KORESELECT Brands KORESELECT products are designed to meet U.S consumer’s health needs as daily health supplements CERRI
